STOCK TITAN

[8-K] Beyond Air, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Beyond Air, Inc. filed an 8-K describing terms that limit the number of common shares issuable on exercise of certain warrants to prevent a holder from exceeding a stated "Beneficial Ownership Limitation." If an exercise would push the holder past that limit, the company will only issue the number of shares that keep the holder below the limit and will hold the remaining shares in abeyance until the holder notifies the company that issuance would comply with the limitation.

The filing lists exhibits including a Form of New Warrant, a Form of Inducement Letter, and a Press Release dated September 8, 2025. The filing also identifies Steven A. Lisi by name.

Beyond Air, Inc. ha depositato un modulo 8-K che descrive clausole che limitano il numero di azioni ordinarie emesse all'esercizio di determinate warrant, in modo da impedire che un detentore superi una specificata “Limitazione di Partecipazione Beneficiaria”. Se l'esercizio dovesse portare il detentore oltre tale limite, la società emetterà soltanto il numero di azioni necessario a mantenere il detentore al di sotto della soglia e tratterrà le azioni residue in sospeso finché il detentore non comunicherà che l'emissione sarebbe conforme alla limitazione.

Il documento elenca gli allegati, tra cui un Modulo di Nuova Warrant, una Lettera di Induzione e un Comunicato Stampa datato 8 settembre 2025. Viene inoltre menzionato il nome di Steven A. Lisi.

Beyond Air, Inc. presentó un formulario 8-K que describe términos que limitan la cantidad de acciones ordinarias que pueden emitirse al ejercer ciertas garantías, para evitar que un titular supere una “Limitación de Participación Beneficiaria” establecida. Si un ejercicio hiciera que el titular superara ese límite, la compañía solo emitirá la cantidad de acciones necesaria para mantener al titular por debajo del límite y retendrá las acciones restantes en suspenso hasta que el titular notifique a la compañía que la emisión cumpliría con la limitación.

La presentación enumera anexos, incluidos un Formato de Nueva Garantía, una Carta de Inducción y un Comunicado de prensa fechado el 8 de septiembre de 2025. También se identifica a Steven A. Lisi por su nombre.

Beyond Air, Inc.는 특정 워런트의 행사로 발행될 보통주 수를 제한하는 조건을 설명하는 8-K를 제출했습니다. 이는 보유자가 정해진 "실질적 소유 제한(Beneficial Ownership Limitation)"을 초과하지 않도록 하기 위한 조치입니다. 만약 행사가 보유자를 그 제한을 넘어서게 할 경우, 회사는 보유자가 제한 이하에 머물도록 하는 데 필요한 수의 주식만 발행하고 나머지 주식은 보유자가 발행이 제한에 부합한다고 통지할 때까지 유보합니다.

해당 제출서류에는 신규 워런트 양식(Form of New Warrant), 유인 서한 양식(Form of Inducement Letter), 및 2025년 9월 8일자 보도자료 등이 첨부된 것으로 기재되어 있습니다. 또한 Steven A. Lisi의 이름이 명시되어 있습니다.

Beyond Air, Inc. a déposé un formulaire 8-K décrivant des modalités limitant le nombre d'actions ordinaires pouvant être émises à l'exercice de certains warrants, afin d'empêcher qu'un détenteur ne dépasse une « Limitation de Participation Bénéficiaire » définie. Si un exercice faisait dépasser ce seuil au détenteur, la société n'émettra que le nombre d'actions nécessaire pour maintenir le détenteur en dessous de la limite et mettra les actions restantes en attente jusqu'à ce que le détenteur informe la société que l'émission respecterait la limitation.

Le dépôt énumère des pièces jointes, notamment un Modèle de nouveau warrant (Form of New Warrant), un Modèle de lettre d'incitation (Form of Inducement Letter) et un Communiqué de presse daté du 8 septembre 2025. Le nom de Steven A. Lisi y est également indiqué.

Beyond Air, Inc. hat ein Formular 8-K eingereicht, das Bestimmungen beschreibt, die die Anzahl der bei Ausübung bestimmter Warrants auszugebenden Stammaktien begrenzen, um zu verhindern, dass ein Inhaber eine festgelegte „Beneficial Ownership Limitation“ überschreitet. Würde eine Ausübung den Inhaber über dieses Limit hinaustreiben, wird die Gesellschaft nur die Anzahl von Aktien ausgeben, die den Inhaber unterhalb des Limits hält, und die verbleibenden Aktien zurückhalten, bis der Inhaber das Unternehmen darüber informiert, dass die Ausgabe der Begrenzung entsprechen würde.

Die Einreichung listet Anlagen auf, darunter ein Formular für die neue Warrant (Form of New Warrant), ein Formular des Inducement Letter und eine Pressemitteilung vom 8. September 2025. Namentlich genannt wird außerdem Steven A. Lisi.

Positive
  • Clear procedural rule for preventing a holder from exceeding a Beneficial Ownership Limitation on warrant exercise
  • Transparency through inclusion of the Form of New Warrant, Form of Inducement Letter, and a press release exhibit
  • Mechanism to hold excess shares in abeyance until issuance would comply with ownership limits
Negative
  • None.

Insights

TL;DR: The filing documents a common warrant anti-dilution control—procedural, not an operational shift.

The disclosed Beneficial Ownership Limitation is a governance measure addressing share issuance mechanics to prevent a single holder from acquiring an outsized ownership stake via warrant exercise. The mechanics—issuing only the number of shares that keep a holder below the limit and placing excess shares in abeyance—are explicit and protect against inadvertent ownership threshold breaches. The inclusion of warrant and inducement forms as exhibits provides transparency about the contractual terms. This appears procedural and routine rather than a material change to business operations or capital structure absent additional context on warrant sizes or holder identity.

TL;DR: Disclosure clarifies exercise mechanics; no clear material impact on valuation from the information provided.

The filing specifies operational rules for warrant exercises that could affect timing of share issuance but does not state the number of warrants, identity of holders (beyond procedural reference), or immediate dilution magnitude. Exhibits listed (new warrant form, inducement letter, press release) are useful for assessing exact terms, yet without quantitative details the investor impact is indeterminate. From a market-perspective this reads as a protective contractual provision rather than a transactional disclosure of material financing or acquisition activity.

Beyond Air, Inc. ha depositato un modulo 8-K che descrive clausole che limitano il numero di azioni ordinarie emesse all'esercizio di determinate warrant, in modo da impedire che un detentore superi una specificata “Limitazione di Partecipazione Beneficiaria”. Se l'esercizio dovesse portare il detentore oltre tale limite, la società emetterà soltanto il numero di azioni necessario a mantenere il detentore al di sotto della soglia e tratterrà le azioni residue in sospeso finché il detentore non comunicherà che l'emissione sarebbe conforme alla limitazione.

Il documento elenca gli allegati, tra cui un Modulo di Nuova Warrant, una Lettera di Induzione e un Comunicato Stampa datato 8 settembre 2025. Viene inoltre menzionato il nome di Steven A. Lisi.

Beyond Air, Inc. presentó un formulario 8-K que describe términos que limitan la cantidad de acciones ordinarias que pueden emitirse al ejercer ciertas garantías, para evitar que un titular supere una “Limitación de Participación Beneficiaria” establecida. Si un ejercicio hiciera que el titular superara ese límite, la compañía solo emitirá la cantidad de acciones necesaria para mantener al titular por debajo del límite y retendrá las acciones restantes en suspenso hasta que el titular notifique a la compañía que la emisión cumpliría con la limitación.

La presentación enumera anexos, incluidos un Formato de Nueva Garantía, una Carta de Inducción y un Comunicado de prensa fechado el 8 de septiembre de 2025. También se identifica a Steven A. Lisi por su nombre.

Beyond Air, Inc.는 특정 워런트의 행사로 발행될 보통주 수를 제한하는 조건을 설명하는 8-K를 제출했습니다. 이는 보유자가 정해진 "실질적 소유 제한(Beneficial Ownership Limitation)"을 초과하지 않도록 하기 위한 조치입니다. 만약 행사가 보유자를 그 제한을 넘어서게 할 경우, 회사는 보유자가 제한 이하에 머물도록 하는 데 필요한 수의 주식만 발행하고 나머지 주식은 보유자가 발행이 제한에 부합한다고 통지할 때까지 유보합니다.

해당 제출서류에는 신규 워런트 양식(Form of New Warrant), 유인 서한 양식(Form of Inducement Letter), 및 2025년 9월 8일자 보도자료 등이 첨부된 것으로 기재되어 있습니다. 또한 Steven A. Lisi의 이름이 명시되어 있습니다.

Beyond Air, Inc. a déposé un formulaire 8-K décrivant des modalités limitant le nombre d'actions ordinaires pouvant être émises à l'exercice de certains warrants, afin d'empêcher qu'un détenteur ne dépasse une « Limitation de Participation Bénéficiaire » définie. Si un exercice faisait dépasser ce seuil au détenteur, la société n'émettra que le nombre d'actions nécessaire pour maintenir le détenteur en dessous de la limite et mettra les actions restantes en attente jusqu'à ce que le détenteur informe la société que l'émission respecterait la limitation.

Le dépôt énumère des pièces jointes, notamment un Modèle de nouveau warrant (Form of New Warrant), un Modèle de lettre d'incitation (Form of Inducement Letter) et un Communiqué de presse daté du 8 septembre 2025. Le nom de Steven A. Lisi y est également indiqué.

Beyond Air, Inc. hat ein Formular 8-K eingereicht, das Bestimmungen beschreibt, die die Anzahl der bei Ausübung bestimmter Warrants auszugebenden Stammaktien begrenzen, um zu verhindern, dass ein Inhaber eine festgelegte „Beneficial Ownership Limitation“ überschreitet. Würde eine Ausübung den Inhaber über dieses Limit hinaustreiben, wird die Gesellschaft nur die Anzahl von Aktien ausgeben, die den Inhaber unterhalb des Limits hält, und die verbleibenden Aktien zurückhalten, bis der Inhaber das Unternehmen darüber informiert, dass die Ausgabe der Begrenzung entsprechen würde.

Die Einreichung listet Anlagen auf, darunter ein Formular für die neue Warrant (Form of New Warrant), ein Formular des Inducement Letter und eine Pressemitteilung vom 8. September 2025. Namentlich genannt wird außerdem Steven A. Lisi.

false 0001641631 0001641631 2025-09-08 2025-09-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): September 8, 2025

 

Beyond Air, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-38892   47-3812456

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

900 Stewart Avenue, Suite 301

Garden City, NY 11530

(Address of Principal Executive Offices and Zip Code)

 

(516) 665-8200

Registrant’s Telephone Number, Including Area Code

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $.0001 per share   XAIR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

On September 8, 2025, Beyond Air, Inc., (“we,” “our,” or the “Company”) entered into an inducement offer letter agreement (the “Inducement Letter”) with 9 holders (each, a “Holder”) of our existing common stock purchase warrants (the “Existing Warrants”) to purchase up to an aggregate of 1,439,126 shares of common stock. The Existing Warrants were issued to the Holders on September 30, 2024, pursuant to that certain Securities Purchase Agreement, dated September 26, 2024. Pursuant to the Inducement Letter, such Holders immediately exercised some or all of their respective outstanding Existing Warrants to purchase up to an aggregate of 1,439,126 shares of common stock, at a reduced exercise price of $2.21. The gross proceeds to the Company from the exercise of the Existing Warrants were approximately $3.18 million, prior to deducting placement agent fees and estimated offering expenses.

 

In consideration for the immediate exercise of some or all of the Existing Warrants for cash, the Company agreed to issue unregistered new common stock purchase warrants (“New Warrants”) to purchase up to 719,561 shares of common stock, for a purchase price of $0.0625 per share of common stock underlying the Existing Warrants held by such holder. The New Warrants will have an exercise price of $2.21 per share, will be immediately exercisable and will have a term of five years from the issuance date.

 

The Inducement Letter also provided that in the event that any exercise of the Existing Warrants would otherwise cause the Holder to exceed a beneficial ownership limitation equal to 4.99% / 9.99% of the number of shares of our common stock outstanding immediately after giving effect to the issuance of shares of common stock issuable upon such exercise (“Beneficial Ownership Limitation”), we shall only issue such number of shares of common stock to the Holder on exercise of the Existing Warrants, that would not cause the Holder to exceed the Beneficial Ownership Limitation, with the balance shares to be held in abeyance until notice from the Holder that the balance (or portion thereof) may be issued in compliance with such limitations.

 

We engaged Laidlaw & Company (UK) Ltd. (“Laidlaw”) as the placement agent in connection with the transactions summarized above and we have agreed to pay Laidlaw a fee equal to 6.5% of the aggregate gross proceeds received from the holder’s exercise of their Existing Warrants. In addition, we have also agreed to reimburse Laidlaw up to $50,000 for its accountable legal expenses in connection with the exercise of the Existing Warrants and the issuance of the New Warrants. The closing of the transactions described above is expected to occur on September 9, 2025 (the “Closing Date”), subject to satisfaction of customary closing conditions. We expect to use the net proceeds from these transactions for general corporate purposes.

 

The shares of our common stock underlying the Existing Warrants have been registered pursuant to an existing registration statement on Form S-3, as amended (File No.: 333-282834) declared effective by the Securities and Exchange Commission (the “SEC”) on November 26, 2024.

 

Pursuant to the Inducement Letter, we also agreed to file a registration statement on Form S-3 providing for the resale of the common stock issuable upon the exercise of the New Warrants (the “Resale Registration Statement”), by September 29, 2025, and to use our best efforts to have such Resale Registration Statement declared effective by the SEC as soon as practicable and to keep the Resale Registration Statement effective at all times until no holder of the New Warrants owns any New Warrants or shares of common stock issuable on exercise of the New Warrants.

 

The forms of the New Warrants and Inducement Letter are filed as Exhibits 4.1 and 10.1, respectively, to this Current Report on Form 8-K and are incorporated herein by reference. The foregoing description of the terms of the New Warrants, and Inducement Letter, is not intended to be complete and is qualified in its entirety by reference to such exhibits. The Inducement Letter contains customary representations, warranties and covenants by us which were made only for the purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and may be subject to limitations agreed upon by the contracting parties.

 

 

 

 

Item 3.02 Unregistered Sales of Equity Securities.

 

The description of the New Warrants under Item 1.01 of this Form 8-K is incorporated by reference herein.

 

The New Warrants will be issued pursuant to the exemption from the registration requirements of the Securities Act available under Section 4(a)(2) and Regulation D issued thereunder. Neither the issuance of the New Warrants nor the common stock issuable upon exercise of the New Warrants have been registered under the Securities Act and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the Securities Act and any applicable state securities laws.

 

Neither this Current Report on Form 8-K nor any exhibit attached hereto is an offer to sell or the solicitation of an offer to buy our securities.

 

Item 7.01 Regulation FD Disclosure.

 

On September 8, 2025, the Company issued a press release announcing the transactions described in Item 1.01 above. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

 

The information reported under Item 7.01 in this Current Report on Form 8-K, including Exhibit 99.1, is being “furnished” and shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Description
4.1   Form of New Warrant
10.1   Form of Inducement Letter
99.1   Press Release dated September 8, 2025
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BEYOND AIR, Inc.
   
Date: September 9, 2025 By: /s/ Steven A. Lisi
  Name: Steven A. Lisi
  Title Chief Executive Officer

 

 

 

 

FAQ

What does the Beneficial Ownership Limitation in the XAIR 8-K mean?

The filing states the company will only issue the number of shares on warrant exercise that keep a holder below the Beneficial Ownership Limitation, and place remaining shares in abeyance until issuance complies with the limit.

Which exhibits are attached to the Beyond Air, Inc. 8-K (XAIR)?

The filing lists a Form of New Warrant, Form of Inducement Letter, and a Press Release dated September 8, 2025 among its exhibits.

Does the 8-K state the number of warrants or shares affected?

No. The provided content does not disclose the number of warrants, total shares affected, or the identity of the holder.

Who is named in the filing?

The filing text identifies Steven A. Lisi by name.

Will excess shares be permanently cancelled under the limitation?

No. The filing specifies excess shares will be held in abeyance until the holder notifies the company that issuance would comply with the ownership limitation.
Beyond Air Inc

NASDAQ:XAIR

XAIR Rankings

XAIR Latest News

XAIR Latest SEC Filings

XAIR Stock Data

17.30M
4.61M
11.88%
10.77%
8.41%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
GARDEN CITY